CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- 4 Open-market sale CEO sold 2,412 shares at $7.10 ($17,125)
- 4 Open-market sale SVP, Chief Accounting Officer sold 1,557 shares at $7.10 ($11,055)
- 4 Open-market sale SVP & Chief Operating Officer sold 2,724 shares at $7.10 ($19,340)
- 4 Open-market sale President sold 3,113 shares at $7.42 ($23,098)
- 4 Open-market buy Director bought 3,500 shares at $5.50 ($19,250)
- 4 Open-market buy Director bought 10,000 shares at $5.37 ($53,700)
- 4 Open-market buy Director bought 1,000 shares at $5.25 ($5,250)
- 4 Open-market buy Director bought 10,000 shares at $5.60 ($56,000)
- 4 Open-market buy Director bought 10,000 shares at $5.55 ($55,500)
- 4 Open-market sale 10% owner sold 197,000 shares at $6.01 ($1,184,837)
- 4 Open-market sale 10% owner sold 110,818 shares at an average $4.41 ($488,911)
- 4 Open-market sale 10% owner sold 105,918 shares at an average $4.44 ($470,730)
- 4 Open-market sale 10% owner sold 78,467 shares at an average $4.51 ($353,737)
- 4 Open-market sale 10% owner sold 60,051 shares at an average $4.69 ($281,343)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 14 · 264 filings